Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas (Q69586028)
Jump to navigation
Jump to search
scientific article published on 01 May 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas |
scientific article published on 01 May 1989 |
Statements
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas (English)
Douglas BR
Woutersen RA
Jansen JB
de Jong AJ
Rovati LC